论文部分内容阅读
目的观察低分子肝素钙联合疏血通治疗进展性脑梗死的临床疗效。方法随机将92例脑梗死患者分为2组,对照组40例,治疗组52例,治疗组给予低分子肝素钙5000U,2次/d皮下注射,连用7d;疏血通针6ml加生理盐水250ml,静脉滴注,1次/d,连用14d;其余常规治疗2组相同。结果治疗后2组临床疗效对比,对照组总有效率65.0%,显效率25.0%;治疗组总有效率90.3%,显效率73.0%。2组比较有统计学意义,P<0.01。结论低分子肝素钙联合疏血通治疗进展性脑梗死疗效显著且安全。
Objective To observe the clinical effect of low molecular weight heparin combined with Shuxuetong in treating progressive cerebral infarction. Methods A total of 92 patients with cerebral infarction were randomly divided into two groups: control group (40 cases) and treatment group (52 cases). The treatment group received low molecular weight heparin 5000U twice a day for 7 days. 250ml, intravenous drip, 1 time / d, once every 14d; other conventional treatment of the same two groups. Results After treatment, the clinical efficacy of the two groups were compared. The total effective rate was 65.0% in the control group and the effective rate was 25.0%. The total effective rate was 90.3% and the effective rate was 73.0% in the treatment group. The two groups were statistically significant, P <0.01. Conclusion Low molecular weight heparin combined with Shuxuetong is effective and safe for the treatment of advanced cerebral infarction.